Skip to main content
. 2022 Jul 6;14(7):1420. doi: 10.3390/pharmaceutics14071420
7-AAD 7-amino-actinomycin D
AD Alzheimer’s Diseases
APC Allophycocyanin
ADHD Attention deficit/hyperactivity disorder
ASD Autism spectrum disorder
BSA bovine serum albumin
CNS Central nervous system
ConA Concanavalin A
DLNs Draining lymph nodes
DMEM Dulbecco’s Modified Eagle Medium
DMF Dimethylfumarate
EAE Experimental autoimmune encephalomyelitis
FBS Fetal bovine serum
FCS Fetal Calf Serum
FTY720 Fingolimod
GBSS Gey’s balanced salt solution
HACTV Horizontal activity
HBSS Hank’s Balanced Salt Solution
HDAC1/2 Histone deacetylase 1 and 2
HPβCD hydroxypropyl-β-cyclodextrin
IC50 Inhibitory concentration 50
KDM1A Lysine (K)-specific demethylase 1A
LSD1 Lysine specific demethylase
MAO-B Monoamine oxidase B
MEM Minimal essential medium
MOG35–55 Myelin oligodendrocyte glycoprotein
MPP+ 1-methyl-4-phenylpyridinium
MPTP 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine
MS Multiple sclerosis
OCT Optimal cutting temperature compound
ORY-1001 Iadademstat
ORY-2001 Vafidemstat
ORY-LSD1 LSD1 selective inhibitor
PBS Phosphate bufferd saline
PE Phycoerythrin
PFU Plaque forming units
PVP-40 Polyvinylpyrrolidone-40
RCOR REST corepressor
S1PRs Sphingosine 1 phosphate receptors
SAMP8 Senescence accelerated mouse prone 8
SAHA Suberoylanilide hydroxamic acid
TBS Tris buffered saline
TCP Tranylcypromine
THA DL-threo-β-hydroxyaspartic
TLR4 Toll-Like Receptor 4
TMEV Theiler’s murine encephalomyelitis virus
TSA Trichostatin A
VACTV Vertical activity